AKU eCommons

Emergence of Genotype 2.3.1 Multidrug-Resistant Salmonella enterica Serovar Typhi Strain, West Africa, 2021-2025.

Since 2021, a genotype 2.3.1, ciprofloxacin-resistant, multidrug-resistant (MDR) Salmonella enterica serovar Typhi strain increasingly has been detected in persons returning from West Africa. This strain locally acquired 2 different MDR plasmids over a ≈25-year period, underwent chromosomal integration of the IncHI1 pl...

SEVERE SALMONELLA WELTEVREDEN GASTROENTERITIS RESISTANCE TO CONVENTIONAL ANTIBIOTICS IN AN INFANT: A CASE REPORT

Presence of globally prominent multidrug-resistant genotypes of Salmonella enterica serovar Typhi in New York State, 2016–2023

The presence of globally dominant resistant genotypes that are likely facilitated by human travel in New York State are revealed, suggesting the spread of high-risk genotypes of international origins to New York State is likely facilitated by human travel.

Acinetobacter bereziniae co-producing NDM-1 and OXA-58 causing pneumonia and stomatitis in a Burmese python (Python bivittatus).

Carbapenemase-producing Acinetobacter (CPA) are multidrug-resistant pathogens mainly associated with healthcare infections but are increasingly detected in wildlife exposed to human environments. In this study we report and characterize a carbapenem-resistant Acinetobacter bereziniae strain related to fatal pneumonia a...

Multidrug-Resistant Acinetobacter baumannii: an Overview of Therapeutic Options and Treatment Regimens

Acinetobacter baumannii, a Gram-negative coccobacillus, is an opportunistic pathogen originating from the natural environment (soil, water, and plants). This bacterium is common in the human skin microbiota and is capable of colonizing diverse environments (e.g., hospital environments). A. baumannii is a bacterium natu...

Genomic epidemiology and emerging antimicrobial resistance profiles of Salmonella Paratyphi A in returning travellers to Australia

Enteric fever is endemic to many low- and middle-income countries (LMICs), particularly those in sub-Saharan Africa, South and South-East Asia. The causative agents are typhoidal serovars of Salmonella enterica, including Typhi (S. Typhi) and Paratyphi A (SPA). There are no vaccines currently licensed for SPA, leaving...